Loading...

Loading...
The most advanced weight loss treatment available, Mounjaro (tirzepatide) delivers superior results for long-term weight management through its unique dual-action formula.

The most advanced weight loss treatment with proven superior results and excellent tolerability.
22.5% average weight loss - the highest among all available treatments
Works on both GLP-1 and GIP receptors for enhanced effectiveness
Well-tolerated with manageable side effects that typically improve over time
Noticeable weight loss typically begins within the first month of treatment
Experience the most comprehensive weight loss benefits with our premium treatment option.
Our expert-guided approach ensures you achieve the best possible results with Mounjaro.
Detailed health evaluation and personalized treatment planning
Carefully managed dose increases to optimize results and minimize side effects
Regular check-ups with our weight management specialists
Complete lifestyle program including nutrition and exercise guidance
Everything you need to know about Mounjaro treatment.
Mounjaro (tirzepatide) is unique as it targets both GLP-1 and GIP receptors, resulting in superior weight loss compared to single-hormone treatments. Clinical studies show up to 22.5% weight loss versus 20.7% with semaglutide-based treatments.
The most common side effects are mild to moderate gastrointestinal symptoms like nausea, diarrhea, and decreased appetite. These typically occur during dose escalation and improve as your body adjusts to the medication.
Most patients begin to see weight loss within the first 4 weeks. Significant results typically become apparent by month 3, with maximum benefits achieved between 6-12 months of treatment.
Mounjaro is suitable for adults with BMI ≥30 or BMI ≥27 with weight-related conditions like diabetes or high blood pressure. Our consultation will assess your individual suitability.
Yes, Mounjaro is also approved for treating type 2 diabetes and can provide dual benefits of weight loss and blood sugar control. However, dose adjustments may be needed if you’re on other diabetes medications.
Mounjaro (tirzepatide) is a prescription medication for weight management. The most common side effects include nausea, diarrhea, decreased appetite, vomiting, constipation, dyspepsia, and abdominal pain. These are typically mild to moderate and decrease over time.
Mounjaro should not be used in patients with a personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2. Tell your healthcare provider about all medications you take.
This medication requires medical supervision and regular monitoring. Our specialists will ensure your treatment is safe and effective throughout your journey.
Experience the most advanced weight loss treatment available. Check your eligibility and start your premium Mounjaro journey today.